Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues
Creator
Balzarini, Jan
Andrei, Graciela
Snoeck, Robert
Naesens, Lieve
Pavelić, Krešimir
Raić-Malić, Silvana
Bratulić, Siniša
Gazivoda, Tatjana
Kraljević-Pavelić, Sandra
Krištafor, Vedran
Makuc, Damjan
Mintas, Mladen
Plavec, Janez
Source
Elsevier; Medline; PMC
abstract
Abstract A series of the novel C-5 alkynyl pyrimidine nucleoside analogues (1–14) in which the sugar moiety was replaced by the conformationally restricted Z- and E-2-butenyl spacer between the phthalimido and pyrimidine ring were synthesized by using Sonogashira cross-coupling reaction. Cytostatic activity evaluation of the novel compounds showed that E-isomers exhibited, in general, better cytostatic activities than the corresponding Z-isomers. E-isomer 14 exhibited the best cytostatic effect against all evaluated malignant cell lines, particularly against hepatocellular carcinoma (Hep G2, IC50 =4.3μM). However, this compound was also cytotoxic to human normal fibroblasts (WI 38). Its Z-isomer 7 showed highly specific antiproliferative activity against Hep G2 (IC50 =18μM) and no cytotoxicity to WI 38. Moreover, compounds 3, 4 and 14 expressed some marginal inhibitory activity against HIV-1 and HIV-2.
has issue date
2008-05-15
(
xsd:dateTime
)
bibo:doi
10.1016/j.bmc.2008.03.074
bibo:pmid
18424155
has license
els-covid
sha1sum (hex)
83ea5f7ec8111775eca183f97073fb98b71a6122
schema:url
https://doi.org/10.1016/j.bmc.2008.03.074
resource representing a document's title
Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues
has PubMed Central identifier
PMC7127491
has PubMed identifier
18424155
schema:publication
Bioorganic & Medicinal Chemistry
resource representing a document's body
covid:83ea5f7ec8111775eca183f97073fb98b71a6122#body_text
is
schema:about
of
named entity 'lines'
named entity 'pyrimidine'
named entity 'cross-coupling reaction'
named entity 'evaluations'
named entity 'NOVEL'
named entity 'FIBROBLASTS'
named entity '282'
named entity 'ACTIVITY'
named entity 'HIV-2'
named entity 'COMPOUND'
named entity 'SYNTHESIZED'
covid:arg/83ea5f7ec8111775eca183f97073fb98b71a6122
named entity 'HIV-1'
named entity 'HEP G2'
named entity 'CYTOTOXICITY'
named entity 'CELL LINES'
named entity 'PYRIMIDINE'
named entity 'ITS'
named entity '287'
named entity 'BEST'
named entity 'CYTOTOXIC'
named entity 'RESTRICTED'
named entity 'CYTOSTATIC'
named entity 'SERIES'
named entity 'SPECIFIC'
named entity 'BETTER'
named entity 'SYNTHESIS'
named entity 'ANTI-HIV'
named entity 'RING'
named entity 'MALIGNANT CELL'
named entity 'REPLACED BY'
named entity 'MOIETY'
named entity 'SUGAR'
named entity 'WI 38'
named entity 'PYRIMIDINE NUCLEOSIDE'
named entity 'UNSATURATED'
named entity 'NEW'
named entity 'EVALUATIONS'
named entity 'INHIBITORY ACTIVITY'
named entity 'USING'
named entity '288'
named entity 'EXPRESSED'
named entity 'CYTOSTATIC'
named entity 'MARGINAL'
named entity 'EFFECT'
named entity 'ANTIPROLIFERATIVE ACTIVITY'
named entity 'COUPLING REACTION'
named entity 'NORMAL'
named entity 'HUMAN'
named entity 'HEPATOCELLULAR CARCINOMA'
named entity 'ACTIVITIES'
named entity 'ISOMER'
named entity '4.3'
named entity 'SONOGASHIRA CROSS-COUPLING'
named entity 'PYRIMIDINE NUCLEOSIDE'
named entity 'EVALUATION'
named entity '283'
named entity 'SPACER'
named entity 'HIGHLY'
named entity 'GENERAL'
named entity 'NUCLEOSIDE ANALOGUES'
named entity 'NUCLEOSIDE ANALOGUES'
named entity 'ACYCLIC'
named entity 'ISOMERS'
named entity 'synthesized'
named entity 'activity'
named entity 'activities'
named entity 'pyrimidine'
named entity 'compounds'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software